Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

Clinical trial NCT05429372 · TERMINATED

Trial details

NCT number: NCT05429372
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Muscular Dystrophy, Duchenne

Start date: 2022-08-08
Primary completion: 2025-10-03
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.